(c) 2024 PillSync.com

pregabalin 100 mg

1 INDICATIONS AND USAGE Pregabalin capsules are indicated for: 1. Management of neuropathic pain associated with diabetic peripheral neuropathy 2. Management of postherpetic neuralgia 3. Adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older 4. Management of fibromyalgia 5. Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved for Pfizer’s LYRICA (pregabalin) Capsules. However, due to Pfizer’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. Pregabalin capsules are indicated for: 1. neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) 2. Postherpetic neuralgia (PHN) ( 1 ) 3. Adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older ( 1 ) 4. fibromyalgia ( 1 ) 5. neuropathic pain associated with spinal cord injury ( 1 )

preferred pharmaceuticals inc.


2 years ago CAPSULE ORANGE APO P100 pregabalin 100 mg

CAPSULE ORANGE APO P100

16 HOW SUPPLIED/STORAGE AND HANDLING Pregabalin capsules 100 mg: Hard gelatin capsules with light orange, opaque body and light orange, opaque cap. Imprinted ‘’APO’’ and ‘’P100’’ in black ink. Bottles of 30: NDC 68788-8359-3 Bottles of 60: NDC 68788-8359-6 Bottles of 90: NDC 68788-8359-9 Bottles of 10: NDC 68788-8359-1 Store pregabalin capsules at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].


More pills like CAPSULE APO P100












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site